A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal ...

The role of the Gastrointestinal Drugs Advisory Committee (GIDAC) is to review and evaluate available data ‘concerning the safety and effectiveness of marketed and investigational human drug ...

Both Prucalopride and the second drug Sunshine Biopharma is planning to launch by year end are in the chronic idiopathic constipation submarket of the total gastrointestinal market currently ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...

end up in the gastrointestinal tract. There, the off-target antibiotics are no match for the number of bacteria, which survive the medication and evolve to be unaffected by the drugs meant to kill ...

Sunshine Biopharma (SBFM) announced that its wholly owned Canadian subsidiary, Nora Pharma, has acquired the rights to two gastrointestinal drugs and already launched one. The second is planned to ...

This and the forthcoming drug are part of Sunshine Biopharma’s strategy to penetrate the chronic idiopathic constipation market, which is part of the larger gastrointestinal market with annual ...

Table 1. Table 1. Precautions to Prevent Irritation of the Esophagus Swallow several sips of water to lubricate the throat before taking a tablet or capsule. Swallow tablet or capsule with at ...